Abstract
Xp21 contiguous gene deletion syndrome is an uncommon genetic condition associated with complex glycerol kinase deficiency (GK), congenital adrenal hypoplasia (NR0B1), Duchenne muscular dystrophy (DMD), and, in some cases, intellectual disability. Clinical findings vary based on the size of the deletion and the number of affected genes. To date, over 100 male patients with this syndrome have been reported, while the number of symptomatic female carriers is quite limited. In this article, we present the diagnosis and treatment process of a case exhibiting dysmorphic facial features, signs of adrenal insufficiency, pseudo-hypertriglyceridemia, and elevated creatine phosphokinase levels. The patient’s serum 17-hydroxyprogesterone levels were normal, and the adrenal glands were not observable via magnetic resonance imaging. An Xp21.2 deletion (DMD, NR0B1, GK, IL1RAPL1) was identified in the case. Treatment with hydrocortisone, fludrocortisone, and oral salt was arranged. This case highlights the rare yet significant clinical and genetic diversity of Xp21 contiguous gene deletion syndrome.
Keywords: Complex glycerol kinase deficiency, congenital adrenal hypoplasia, Duchenne muscular dystrophy, glycerol kinase deficiency, pseudo-hypertriglyceridemia
Read the full text
4 sections · 3 figures · 2 tables · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Dipple KM, Zhang YH, Huang BL, McCabe LL, Dallongeville J, Inokuchi T, Kimura M, Marx HJ, Roederer GO, Shih V, Yamaguchi S, Yoshida I, McCabe ER. Glycerol kinase deficiency: evidence for complexity in a single gene disorder. Hum Genet. 2001;109:55-62.
Sehgal A, Stack J. Complex glycerol kinase deficiency: an X-linked disorder associated with adrenal hypoplasia congenita. Indian J Pediatr. 2005;72:67-69.
Ramanjam V, Delport S, Wilmshurst JM. The diagnostic difficulties of complex glycerol kinase deficiency. J Child Neurol. 2010;25:1269-1271. Epub 2010 Jan 28
Korkut S, Baştuğ O, Raygada M, Hatipoğlu N, Kurtoğlu S, Kendirci M, Lyssikatos C, Stratakis CA. Complex glycerol kinase deficiency and adrenocortical insufficiency in two neonates. J Clin Res Pediatr Endocrinol. 2016;8:468-471. Epub 2016 Apr 18
Heide S, Afenjar A, Edery P, Sanlaville D, Keren B, Rouen A, Lavillaureix A, Hyon C, Doummar D, Siffroi JP, Chantot-Bastaraud S. Xp21 deletion in female patients with intellectual disability: two new cases and a review of the literature. Eur J Med Genet. 2015;58:341-345. Epub 2015 Apr 23
Shaikh MG, Boyes L, Kingston H, Collins R, Besley GT, Padmakumar B, Ismayl O, Hughes I, Hall CM, Hellerud C, Achermann JC, Clayton PE. Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita. J Med Genet. 2008;45:e1.
Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res. 2001;55:201-205.
Al-Alwan I, Navarro O, Daneman D, Daneman A. Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia. J Pediatr. 1999;135:71-75.
Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalmic and pituitary defects in gonadotropin production. J Clin Invest. 1996;98:1055-1062.
McCabe ER. DAX1: Increasing complexity in the roles of this novel nuclear receptor. Mol Cell Endocrinol. 2007;265-266:179-182. Epub 2007 Jan 8
Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nat Genet. 1999;22:125-126.
Bergadá I, Del Rey G, Lapunzina P, Bergadá C, Fellous M, Copelli S. Familial occurrence of the IMAGe association: additional clinical variants and a proposed mode of inheritance. J Clin Endocrinol Metab. 2005;90:3186-3190. Epub 2005 Mar 15
Hellerud C, Wramner N, Erikson A, Johansson A, Samuelson G, Lindstedt S. Glycerol kinase deficiency: follow-up during 20 years, genetics, biochemistry and prognosis. Acta Paediatr. 2004;93:911-921.
Francke U, Harper JF, Darras BT, Cowan JM, McCabe ER, Kohlschütter A, Seltzer WK, Saito F, Goto J, Harpey JP, et al. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions. Am J Hum Genet. 1987;40:212-227.
Sjarif DR, Hellerud C, van Amstel JK, Kleijer WJ, Sperl W, Lacombe D, Sass JO, Beemer FA, Duran M, Poll-The BT. Glycerol kinase deficiency: residual activity explained by reduced transcription and enzyme conformation. Eur J Hum Genet. 2004;12:424-432.
Rughani A, Blick K, Pang H, Marin M, Meyer J, Tryggestad JB. Pseudohypertriglyceridemia: a novel case with ımportant clinical ımplications. Case Rep Pediatr. 2020;2020:4609317.
Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. J Paediatr Child Health. 2015;51:759-764. Epub 2015 Mar 9
Nardes F, Araújo AP, Ribeiro MG. Mental retardation in Duchenne muscular dystrophy. J Pediatr (Rio J). 2012;88:6-16.
Tao N, Liu X, Chen Y, Sun M, Xu F, Su Y. Delayed diagnosis of complex glycerol kinase deficiency in a Chinese male infant: a case report. BMC Pediatr. 2022;22:517.
Islas Abdenur M. Complex glycerol kinase deficiency: a case report. Arch Argent Pediatr. 2025;123:e202410354. Epub 2024 Nov 7
Pizza A, Picillo E, Onore ME, Scutifero M, Passamano L, Nigro V, Politano L. Xp21 contiguous gene deletion syndrome presenting as Duchenne muscular dystrophy and glycerol kinase deficiency associated with intellectual disability: case report and review literature. Acta Myol. 2023;42:24-30.
Bi S, Dai L, Jiang L, Wang L, Teng M, Liu G, Teng RJ. Chronic granulomatous disease associated with Duchenne muscular dystrophy caused by Xp21.1 contiguous gene deletion syndrome: case report and literature review. Front Genet. 2023;13:970204.
Rathnasiri A, Senarathne U, Arunath V, Hoole T, Kumarasiri I, Muthukumarana O, Jasinge E, Mettananda S. A rare co-occurrence of duchenne muscular dystrophy, congenital adrenal hypoplasia and glycerol kinase deficiency due to Xp21 contiguous gene deletion syndrome: case report. BMC Endocr Disord. 2021;21:214.
Wikiera B, Jakubiak A, Łaczmanska I, Noczyńska A, Śmigiel R. Complex glycerol kinase deficiency - long-term follow-up of two patients. Pediatr Endocrinol Diabetes Metab. 2021;27:227-231.
Liu L, Wang L, Jiao Z, Kong X. [Diagnosis of a patient with adjacent gene deletion syndrome with DMD complete deletion type of Duchenne muscular dystrophy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021;38:869-872.
Sevim U, Fatma D, Ihsan E, Gulay C, Nevin B. A neonate with contiguous deletion syndrome in XP21. J Pediatr Endocrinol Metab. 2011;24:1095-1098.
Jamroz E, Paprocka J, Popowska E, Pytel J, Ciara E, Adamowicz M. Xp21.2 contiguous gene syndrome due to deletion involving glycerol kinase and Duchenne muscular dystrophy loci. Neurol India. 2010;58:670-671.
Sanz-Ruiz I, Bretón-Martínez JR, Del Castillo-Villaescusa C, Cásanovas-Martínez A, Martínez-Castellano F, Millán-Salvador JM, Hernández-Marco R, Codoñer-Franch P. Síndrome de deleción de genes contiguos en Xp21: una forma inusual de presentación [Contiguous gene deletion syndrome in Xp21: an unusual form of presentation]. Rev Neurol. 2009;49:472-474.
Pantoja-Martínez J, Martínez-Castellano F, Tarazona-Casany I, Buesa-Ibáñez E, Ardid-Encinar M, Esparza-Sánchez MA, Bonet-Arzo J. Sindrome de deleción de genes contiguos en Xp21: asociación de deficiencia de glicerolcinasa, hipoplasia suprarrenal congénita y distrofia muscular de Duchenne [Contiguous gene deletion syndrome in Xp21: the association between glycerol kinase deficiency, congenital suprarenal hypoplasia and Duchenne’s muscular dystrophy]. Rev Neurol. 2007;44:606-609.
Ma HW, Jiang J, Wang YP, Wang ZC, Chen LY, Masafumi M. Gene deletion analysis of a Chinese boy with Xp21 contiguous gene deletion syndrome. Chinese Medical Journal, 2004;117;789-791.
